PETROS PHARMACEUTICALS INC's ticker is and the CUSIP is 71678J209. A total of 15 filers reported holding PETROS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EMFO, LLC | 1,000 | $1,730 | 0.00% |
| Newbridge Financial Services Group, Inc. | 120 | $208 | 0.00% |
| VANGUARD GROUP INC | 31,811 | $55,030 | 0.00% |
| Schonfeld Strategic Advisors LLC | 22,700 | $39,268 | 0.00% |
| OSAIC HOLDINGS, INC. | 14 | $24 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 1 | $2 | 0.00% |
| FIRST MANHATTAN CO. LLC. | 10 | $17 | 0.00% |
| WELLS FARGO & COMPANY/MN | 11 | $19 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 79 | $131 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 10,502 | $17,433 | 0.00% |
| MORGAN STANLEY | 19 | $32 | 0.00% |
| BlackRock Inc. | 16,510 | $28,561 | 0.00% |
| Citadel Advisors | 14,288 | $23,718 | 0.00% |
| Tower Research Capital LLC (TRC) | 2,542 | $4,398 | 0.00% |
This page lists PETROS PHARMACEUTICALS INC's shareholders in Q3 2023. To view PETROS PHARMACEUTICALS INC's shareholder history, click here.